cg702.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 

 
SCHEDULE 13G/A
(Amendment No. 2)
 
Under the Securities Exchange Act of 1934

 
 
Raptor Pharmaceutical Corporation

(Name of Issuer)
Common stock, par value $0.001 per share

(Title of Class of Securities)
75382F106

(CUSIP Number)
December 31, 2015

(Date of Event Which Requires Filing of this Statement)
 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 
    o
Rule 13d-1(b)
 
    x
Rule 13d-1(c)
 
    o
Rule 13d-1(d)
 
 
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
(Continued on following pages)

 
 

 

CUSIP No. 75382F106
 
1.
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Bidzina Ivanishvili
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
 
(a)   x
(b)   o
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
French
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH:
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
4,364,286 ordinary shares
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
4,364,286 ordinary shares
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
4,364,286 ordinary shares*
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES
 
 o
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.13%
12.
TYPE OF REPORTING PERSON
IN

* See explanatory note included in Item 4.

 
2

 


CUSIP No. 75382F106
 
1.
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
George Bachiashvili
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
 
(a)   x
(b)   o
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Georgian
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH:
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
4,364,286 ordinary shares
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
4,364,286 ordinary shares
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
4,364,286 ordinary shares*
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES
 
 o
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.13%
12.
TYPE OF REPORTING PERSON
IN

* See explanatory note included in Item 4.

 
3

 



CUSIP No. 75382F106
 
1.
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Meadowsweet Assets Limited
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
 
(a)   x
(b)   o
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH:
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
4,364,286 ordinary shares
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
4,364,286 ordinary shares
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
4,364,286 ordinary shares*
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES
 
 o
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.13%
12.
TYPE OF REPORTING PERSON
CO

* See explanatory note included in Item 4.

 
4

 


CUSIP No. 75382F106
 
1.
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Credit Suisse Trust Limited in its capacity as trustee of The Mandalay Trust
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
 
(a)   x
(b)   o
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Singapore
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH:
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
4,364,286 ordinary shares
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
4,364,286 ordinary shares
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
4,364,286 ordinary shares*
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES
 
 o
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.13%
12.
TYPE OF REPORTING PERSON
CO

* See explanatory note included in Item 4.

 
5

 


ITEM 1(a).
NAME OF ISSUER:
 
 
Raptor Pharmaceutical Corporation (the “Issuer”)
 
ITEM 1(b).
ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
 
 
5 Hamilton Landing, Suite 160, Novato, California 94949, United States
 
ITEM 2(a).
NAME OF PERSON FILING:
 
 
Bidzina Ivanishvili
 
 
George Bachiashvili
 
 
Meadowsweet Assets Limited (the “Record Holder1”)
 
 
Credit Suisse Trust Limited (the “Trustee”) in its capacity as trustee of The Mandalay Trust (the “Trust”)
 
ITEM 2(b).
ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:
 
 
The address of the principal business office of Bidzina Ivanishvili is Sololaky Alley 6, 0105 Tbilisi, Georgia. The address of the principal business office of George Bachiashvili is N57, Irakli Abashidze Str., Tbilisi, Georgia.  The address of the principal business office of the Record Holder1 is Akara Building, 24 De Castro Street, Wickhams Cay 1, P.O. Box 3136, Road Town, Torola, British Virgin Islands. The address of the Trust and the Trustee is 1 Raffles Link, #05-02 Singapore 039393.

ITEM 2(c)
CITIZENSHIP:
 
 
Bidzina Ivanishvili is a citizen of France and Georgia. George Bachiashvili is a citizen of Georgia.  The place of organization of the Record Holder1 is the British Virgin Islands.  The place of organization of the Trustee is Singapore.  The Trust is established under the laws of Singapore.
 
ITEM 2(d).
TITLE OF CLASS OF SECURITIES:
 
 
Common stock
 
ITEM 2(e).
CUSIP NUMBER:
 
75382F106

ITEM 3.
Not Applicable
 

 
 
6

 

ITEM 4.
OWNERSHIP:
 
 
Reporting Person
 
(a)
Amount
beneficially owned:
 
(b)
Percent of class*:
 
(c)(i)
Sole power to vote or direct
the vote:
 
(c)(ii) Shared power to vote or to direct
the vote:
 
(c)(iii)
Sole power to dispose or to direct the disposition of:
 
(c)(iv) Shared power to dispose or to direct the disposition of:
             
Bidzina Ivanishvili
4,364,286
5.13%
0
4,364,286
0
4,364,286
             
George Bachiashvili
4,364,286
5.13%
0
4,364,286
0
4,364,286
             
Meadowsweet Assets Limited
4,364,286
5.13%
0
4,364,286
0
4,364,286
             
Credit Suisse Trust Limited**
4,364,286
5.13%
0
4,364,286
0
4,364,286

 
* Based upon 85,101,239 ordinary shares issued as of November 4, 2015.
 
** In its capacity as trustee of the Trust.
 
 
The Record Holder1 beneficially owns 4,364,286 shares of common stock of the Issuer. Record Holder1 is wholly owned by the Trust, of which the Trustee acts as the trustee. Bidzina Ivanishvili is the settlor of the Trust. George Bachiashvili is an investment manager of the Trust. Bidzina Ivanishvili, George Bachiashvili, Record Holder1 and the Trustee in its capacity as trustee for the Trust may be deemed to be a group for the shares of common stock as defined in Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended, and each member of such group may be deemed to beneficially own the ordinary shares beneficially owned by other members constituting such group. The Trustee disclaims beneficial ownership of the ordinary shares. The filing of this Schedule 13G should not be deemed an admission that the Trustee is the beneficial owner of such ordinary shares for any purpose.
 
ITEM 5.
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
 
 
Not applicable.
 
ITEM 6.
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

 
Not applicable

 
7

 
 

ITEM 7.
IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON:

 
Not applicable

ITEM 8.
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

 
See Item 4.

ITEM 9.
NOTICE OF DISSOLUTION OF GROUP:
 
 
Not applicable
 
ITEM 10.
CERTIFICATION:
 
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
 

 
8

 

SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated:  February 12, 2016
 
Bidzina Ivanishvili
/s/ Bidzina Ivanishvili
 
Name:   Bidzina Ivanishvili
   
   
George Bachiashvili
/s/ George Bachiashvili
 
Name:   George Bachiashvili
   
   
Meadowsweet Assets Limited
For and on behalf of
Bukit Merah Limited
Corporate Director
   
 
By:  /s/ Lua Chew Lui
 
Name:  Lau Chew Lui
   
 
By:  /s/ Dominik Birri
 
Name:  Dominik Birri
   
   
Credit Suisse Trust Limited
Credit Suisse Trust Limited in its capacity as trustee of The Mandalay Trust
   
 
By:  /s/ Lua Chew Lui
 
Name:  Lau Chew Lui
   
 
By:  /s/ Dominik Birri
 
Name:  Dominik Birri


 
9

 


  LIST OF EXHIBITS
 

Exhibit No.
Description
   
  A   Jount Filing Agreement

 

 
 

 

EXHIBIT A
 
Joint Filing Agreement
 
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common stock, par value $0.001 per share, of Raptor Pharmaceutical Corporation, a Delaware corporation, and that this Agreement may be included as an Exhibit to such joint filing.  This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
 
[Remainder of this page has been left intentionally blank.]

 
 

 

Signature Page
 
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of the day of February 12, 2016.
 
 
Bidzina Ivanishvili
/s/ Bidzina Ivanishvili
 
Name:   Bidzina Ivanishvili
   
   
George Bachiashvili
/s/ George Bachiashvili
 
Name:   George Bachiashvili
   
   
Meadowsweet Assets Limited
For and on behalf of
Bukit Merah Limited
Corporate Director
   
 
By:  /s/ Lua Chew Lui
 
Name:  Lau Chew Lui
   
 
By:  /s/ Dominik Birri
 
Name:  Dominik Birri
   
   
Credit Suisse Trust Limited
Credit Suisse Trust Limited in its capacity as trustee of The Mandalay Trust
   
 
By:  /s/ Lua Chew Lui
 
Name:  Lau Chew Lui
   
 
By:  /s/ Dominik Birri
 
Name:  Dominik Birri